Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Agenerase (amprenavir) Capsules and Solution, GlaxoSmithKline NDA 21-007/S14 & S15 NDA 21-039/S13 & S14 10/2/02 10/11/01 10/3/02 Agenerase (amprenavir) Capsules and Solution, GlaxoSmithKline NDA 21-007/S11 NDA 21-039/S10 8/2/02 8/6/02 8/5/02 Agenerase (amprenavir) Capsules and Solution, GlaxoSmithKline NDA 21-007/S10, & 13 NDA 21-039/S9 & 12 2/5/02 4/17/02 Agenerase (amprenavir) Capsules and Solution, 50mg, 150mg Glaxo Wellcome NDA 21-007 NDA 21-039 4/15/99 7/24/02 5/25/99 7/24/02 Agenerase Indication: for the treatment of HIV-1 infection. | Agenerase (amprenavir) Capsules and Solution, GlaxoSmithKline NDA 21-007/S6 NDA 21-039/S6 Agenerase (amprenavir) Capsules and Oral Solution, GlaxoSmithKline | AGENERASE (amprenavir) Capsules, GlaxoSmithKline, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com